In QuotedData’s morning briefing 30 June 2021: International Public Partnerships is looking to raise money by issuing shares at 165p, a 15% premium to the end December 2020 NAV (adjusted for the 3.68p dividend declared since). The company has £56m of drawings on its debt facility and upcoming investments worth about £100m, including its investment in […]
Bluefield Solar buys wind portfolio – Bluefield Solar has entered into a conditional sale and purchase agreement to acquire a portfolio of 109 small scale onshore wind turbines located across the UK for an aggregate consideration of approximately £60m (including working capital) from Arena Capital Partners Limited. The deal is conditional upon Bluefield securing the necessary […]
QD view – Chinese private equity and why Fidelity China wants more of it. We have seen a welcome improvement in discounts on private equity trusts in recent months. For example, Oakley Capital has moved from trading on a 30% discount in March to around 11% today, while Apax Global Alpha, which saw its shares […]
Seraphim Space prospectus published The Seraphim Space Investment Trust prospectus is out and, as promised, we are making it available here. As always, we are not recommending that you buy the shares. In fact we are not acting in any capacity with respect to the IPO. The prospectus is just provided for your convenience. There […]
The world is a different place than it was 18 months ago. COVID-19 and the ramifications of the lockdowns used to contain it have changed the investment landscape considerably. In a relatively short period of time, we have gone from concerns that we were approaching the tail end of a long bull market, to a […]
RTW backs Umoja Biopharma – Umoja Biopharma, Inc. has just completed a $210m Series B financing round. RTW Venture Fund participated in the financing round together with other investment firms, including other investment vehicles of RTW Investments, LP. Umoja is a US-based privately held oncology company. It is using a new approach to immunotherapy, reprogramming immune cells directly […]
As an analyst in the investment companies sector, one of the exciting things is that asset managers are always dreaming up new ideas for funds to launch. I can go from looking at Asian smaller companies in the morning to European renewable energy in the afternoon. Already this year we have seen the launch of […]
The UK Residential REIT prospectus is out and, as promised, we are making it available here. As always, we are not recommending that you buy the shares. In fact we are not acting in any capacity with respect to the IPO. The prospectus is just provided for your convenience. There are geographic restrictions on who can invest in […]
GCP Infrastructure Investments has announced interim results covering the six months ended 31 March 2021. Highlights are: NAV at 31 March 2021 of 100.78p (31 March 2020: 109.83p) Total shareholder return for the period of -8.8% (31 March 2020: -8.1%) and total shareholder return since IPO in 2010 of 100.3% Dividends of 3.5p per share paid for the six […]
JLEN NAV declines on tax hike and power prices – JLEN Environmental has published its results covering the year ended 31 March 2021. The NAV has fallen from 97.5p to 92.2p. This reflects the planned increase in UK corporation tax, from 19% to 25% from April 2023, and a downward revision to electricity and gas price […]
